About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Flow-synchronized Nasal IMV in Preterm Infants

NCT02085499·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Miami

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Preterm infants of 30 or less weeks of gestational age
Receiving NIMV
Requiring Fi02 \> 0.21 to keep Sp02 \> 90%
Parental written informed consent

You may not be if

Major congenital anomalies
Proven sepsis within 72 hours of the study
Hypotension requiring pressors within 72 hours of the study
Pneumothorax or pneumomediastinum within 72 hours of the study
Current suspected necrotizing enterocolitis, spontaneous perforation or severe abdominal distention

The record

StatusCompleted

PhaseNo phase

Taking part11

StartedMar 2014

UpdatedMay 16, 2024

Conditions

Premature Infant Disease Respiratory Insufficiency

Where1

Holtz Childrens Hospital-Jackson Health System-University of Miami
Miami, Florida, United States

Clareo Health | Flow-synchronized Nasal IMV in Preterm Infants